Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever

American Journal of Tropical Medicine and Hygiene

Volumn 79, Issue 2, 2008, Pages 149-153

  Lee, Ing Kit ^a   Liu, Jien Wei ^a,b   Yang, Kuender D ^a,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; AGED; ARTICLE; BACTEREMIA; BONE PAIN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DENGUE; FATALITY; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; GERIATRIC PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PROTHROMBIN TIME; RASH; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

EID: 49449100647     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.79.149     Document Type: Article

References (38)

1. Gibbons RV, Vaughn DW, 2002. Dengue: an escalating problem. BMJ 324: 1563-1566.
2. Pinheiro FP, Corber SJ, 1997. Global situation of dengue and dengue hemorrhagic fever, and its emergence in the Americas. World Health Stat Q 50: 161-169.
3. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV, 1998. Dengue and dengue hemorrhagic fever. Lancet 352: 971-977.
4. World Health Organization, 1997. Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control. Geneva: World Health Organization.
5. Liu JW, Khor BS, Lee CH, Lee IK, Chen RF, Yang KD, 2003. Dengue hemorrhagic fever in Taiwan. Dengue Bull 27: 19-23.
6. Lee IK, Liu JW, Yang KD, 2005. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg 72: 221-226.
7. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, Ma'roef C, Sutaryo E, Porter KR, Halstead SB, 1999. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg 61: 412-419.
8. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, Phanthumachinda B, Halstead SB, 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120: 653-669.
9. Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB, 2002. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis 6: 118-124.
10. Garcia-Rivera EJ, Rigau-Perez JG, 2003. Dengue severity in the elderly in Puerto Rico. Pan Am J Public Health 13: 362-368.
11. World Health Organization, 1989. Health of the Elderly: Report of a WHO Expert Committee. Geneva: World Health Organization.
12. Shu PY, Chen LK, Chang SF, Yuen YY, Chow L, Chien LJ, Chin C, Yang HH, Lin TH, Huang JH, 2002. Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test. J Clin Microbiol 40: 1840-1844.
13. Chen RF, Yeh WT, Yang MY, Yang KD, 2001. A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunol Med Microbiol 1278: 1-7.
14. Gorman M, 1999. Development and rights of the older people. Randel J, Germen T, Ewing D, eds. The Ageing and Development Report: Poverty, Independence and the World's Older People. London: Earthscan Publications, 3-21.
15. Engel JM, Deitch EA, Sikkema W, 1980. Gallbladder wall thickness: sonographic accuracy and relation to disease. AJR Am J Roentgenol 134: 907-909.
16. Hoste EA, Kellum JA, 2006. Acute kidney injury: epidemiology and diagnostic criteria. Curr Opin Crit Care 12: 531-537.
17. Knochel JP, 1993. Mechanisms of rhabdomyolysis. Curr Opin Rheumatol 5: 725-731.
18. Lloyd-Sherlock P, 2000. Population ageing in developed and developing regions: implications for health policy. Soc Sci Med 51: 887-895.
19. Doggett DL, Chang MP, Makinodan T, Strehler BL, 1981. Cellular and molecular aspects of immune system aging. Mol Cell Biochem 37: 137-156.
20. Finkelstein MS, 1985. Aging immunocytes and immunity. Characteristics and significance. Clin Geriatr Med 1: 899-911.
21. Goldstein S, 1971. The biology of aging. N Engl J Med 285: 1120-1129.
22. van Gorp EC, Minnema MC, Suharti C, Mairuhu ATA, Brandjes DPM, Cate HT, Hack CE, Meijers JCM, 2001. Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever. Br J Haematol 113: 94-99.
23. Huang YH, Liu CC, Wang ST, Lei HY, Liu HL, Lin YS, Wu HL, Yen TM, 2001. Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol 63: 247-251.
24. Chua MN, Molanida R, de Guzman M, Laberiza F, 1993. Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 24 (Suppl 1): 141-143.
25. Lim M, Goh HK, 2005. Rhabdomyolysis following dengue virus infection. Singapore Med J 46: 645-646.
26. Davis JS, Bourke P, 2004. Rhabdomyolysis associated with dengue virus infection. Clin Infect Dis 38: e109-e111.
27. Gunasekera HH, Adikaram AV, Herath CA, Samarasinghe HH, 2000. Myoglobinuric acute renal failure following dengue viral infection. Ceylon Med J 45: 181.
28. Wiwanitkit V, 2005. Acute renal failure in the fatal cases of dengue hemorrhagic fever, a summary of Thai death cases. Ren Fail 27: 647.
29. Druml W, Lax F, Grimm G, Schneeweiss B, Lenz K, Laggner AN, 1994. Acute renal failure in the elderly 1975-1990. Clin Nephrol 41: 342-349.
30. Kuo MC, Chang JM, Lu PL, Chiu YW, Chen HC, Hwang SJ, 2007. Difficulty in diagnosis and treatment of dengue hemorrhagic fever in patients with chronic renal failure: report of three cases of mortality. Am J Trop Med Hyg 76: 752-756.
31. Morens DM, 1994. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 19: 500-512.
32. Guzmán MG, Alvarez M, Rodríguez R, Rosario D, Vázquez S, Vald sL, Cabrera MV, Kourí G, 1999. Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis 3: 130-135.
33. Scott RM, Nimmannitya S, Bancroft WH, Mansuwan P, 1976. Shock syndrome in primary dengue infections. Am J Trop Med Hyg 25: 866-874.
34. Guzmán MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L, 1990. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 42: 179-184.
35. de la C Sierra B, Kourí G, Guzmán MG, 2007. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152: 533-542.
36. Bravo JR, Guzmán MG, Kouri GP, 1987. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 81: 816-820.
37. Dung NM, Day NP, Tam DT, Loan HT, Chau HT, Minh LN, Diet TV, Bethell DB, Kneen R, Hien TT, White NJ, Farrar JJ, 1999. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 29: 787-794.
38. Ranjit S, Kissoon N, Jayakumar I, 2005. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol. Pediatr Crit Care Med 6: 412-419.